Cambridge Molecular
DNA-encoded library analysis and virtual-screening software for drug discovery teams
Highlights
- New on EvolcAdded 2026-11-05
About Cambridge Molecular
Cambridge Molecular develops the Palladium DEL Follow-Up Suite, downloadable software for DNA-encoded library data analysis, virtual screening and hit resynthesis prioritisation. Its tools include PocketMapper, DELNexus and ShapeRetriever.
The software is for drug discovery researchers working with DEL datasets. Cambridge Molecular is based in Cambridge, United Kingdom, and was founded in 2019.
Product: Palladium is downloadable software for DNA-encoded library analysis, virtual screening and resynthesis prioritisation.
Jobs at Cambridge Molecular
More biotech & pharma companies
Carus Animal Health
Animal health company developing point-of-care diagnostics and antibiotic alternatives for vets, farms and aquacultureNew on EvolcCatsci
Outsourced drug development R&D for biotech and pharma teams, covering small molecule and complex synthetic medicinesNew on EvolcCauseway Sensors
Bioprocess sensor for at-line, real-time IgG quantification in bioreactor samples, for biopharma bioproduction teamsNew on EvolcCellcentric
Develops an oral cancer drug for people with multiple myeloma and other cancersNew on EvolcCellcraft
AI bioprocess control software and related tools for biomanufacturers and bioprocess teams
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- DjangoMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.